Effects of Anti-Asthma Agents on Cytokine and Prostaglandin Production in Ovalbumin-Sensitized Splenocytes |
Won, Tae-Joon
(Department of Immunology, College of Pharmacy, Chung-Ang University)
Lee, Chan-Woo (Department of Immunology, College of Pharmacy, Chung-Ang University) Kwon, Seok-Joong (Department of Immunology, College of Pharmacy, Chung-Ang University) Lee, Do-Ik (Department of Immunology, College of Pharmacy, Chung-Ang University) Park, So-Young (Environmental Toxico-genomic and Proteomic Center, College of Medicine, Korea University) Hwang, Kwang-Woo (Department of Immunology, College of Pharmacy, Chung-Ang University) |
1 | Black, J. L., Armour, C. L., Vincenc, K. S. and Johnson, P. R. (1986). A comparison of the contractile activity of PGD2 and PGF2 alpha on human isolated bronchus. Prostaglandie 32, 25-31. DOI ScienceOn |
2 | Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., Eguchi, N., Urade, Y., Yoshida, N., Kimura, K., Mizoguchi, A., Honda, Y., Nagai, H. and Narumiya, S. (2000). Prostaglandin D2 as a mediator of allergic asthma. Science. 287, 2013-2017. DOI ScienceOn |
3 | Oh, J. W., Lee, H. B., Chung, Y. H. and Choi, Y. (2002). The effect of disodium cromoglycate, budesonide, and cyclosporin A on interleukin-4, interleukin-5, and interleukin-13 secretions in Der p I-stimulated T cells from house dust mite-sensitive atopic and nonatopic individuals. Allergy Asthma Proc. 23, 109-115. |
4 | Takahashi, Y., Tokuoka, S., Masuda, T., Hirano, Y., Nagao, M., Tanaka, H., Inagaki, N., Narumiya, S. and Nagai, H. (2002). Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137, 315-322. DOI ScienceOn |
5 | Umetsu, D. T. and DeKruyff, R. H. (1997). Th1 and Th2 CD4+ cells in human allergic diseases. J. Aller. Clin. Immunol. 100, 1-6. DOI ScienceOn |
6 | Wenzel, S. E., Westcott, J. Y. and Larsen, G.L. (1991). Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. J. Allergy Clin. Immunol. 87, 540-548. DOI |
7 | Wills-Krap, M, Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., and Donaldson, D. D. (1998). Interleukin-13: central mediator of allergic asthma. Science. 282, 2258-2261. DOI ScienceOn |
8 | Nagai, H., Arimura, A., Yoshitake, K., Iwama, T., Sakurai, T. and Koda, A. (1993). The effect of a novel thromboxane A2 (TXA2) receptor antagonist (S-1452) on the antigen-induced bronchoconstriction and airway hyperresponsiveness in guinea pigs. Prostaglandins Leukot Essent Fatty Acids. 48, 343-349. DOI ScienceOn |
9 | Miadonna, A., Tedeschi, A., Brasca, C., Folco, G., Sala, A. and Murphy, R. C. (1990). Mediator release after endobronchial antigen challenge in patients with respiratory allergy. J. Allergy Clin. Immunol. 85, 906-913. DOI |
10 | Mohede, I. C., Van Ark, I., Brons, F. M., Van Oosterhout, A. J. and Nijkamp, F. P. (1996). Salmeterol inhibits interferongamma and interleukin-4 production by human peripheral blood mononuclear cells. Int. J. Immunopharmacol. 18, 193-201. DOI ScienceOn |
11 | Nagata, K., Tanaka, K., Ogawa, K., Kemmotsu, K., Imai, T., Yoshie, O., Abe, H., Tada, K., Nakamura, M., Sugamura, K. and Takano, S. (1999). Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162, 1278-1286. |
12 | Narumiya, S., Sugimoto, Y. and Ushikubi, F. (1999). Prostanoid receptors: structures, properties, and functions. Physiol Rev. 79, 1193-1226. DOI |
13 | Nauta, A. J., Engels, F., Knipples, L. M., Garssen, J., Nijkamp, F. P. and Redegeld, F. A. (2008). Mechanisms of allergy and asthma. Eur. J. Pharmacol. 585, 354-360. DOI ScienceOn |
14 | Marom, Z., Shelhamer, J.H. and Kaliner, M. (1981). Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro. J. Clin. Invest. 67, 1695-1702. DOI |
15 | Peters, S. P. (2003). Heterogeneity in the pathology and treatment of asthma. Am. J. Med. 115(Suppl 3A), 49S-54S. DOI ScienceOn |
16 | Sturm, E. M., Schratl, P., Schuligoi, R., Konya, V., Sturm, G. J., Lippe, I. T., Peskar, B. A. and Heinemann, A. (2008). Prostaglandin E2 inhibits eosinophil trafficking through Eprostanoid 2 receptors. J. Immunol. 181, 7273-7283. DOI |
17 | Houtman, R. and van den Worm, E. (2005). Asthma, the ugly duckling of lung disease proteomics? J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 815, 285-294. DOI ScienceOn |
18 | Leal-Berumen, I., O'Byrne, P., Gupta, A., Richards, C. D. and Marshall J. S. (1995). Prostanoid enhancement of interleukin- 6 production by rat peritoneal mast cells. J Immunol. 154, 4759-4767. |
19 | Matsuo, N., Shimoda, T., Matsuse, H., Obase, Y., Asai, S. and Kohno, S. (2000). Effects of sodium cromoglycate on cytokine production following antigen stimulation of a passively sensitized human lung model. Ann. Allergy Asthma Immunol. 84, 72-78. DOI ScienceOn |
20 | Turner, N. C., Fuller, R. W. and Jackson, D. M. (1995). Eicosanoid release in allergen-induced bronchoconstriction in dogs. Its relationship to airways hyperreactivity and pulmonary inflammation. J. Lipid Mediat. Cell Signal. 11, 93-102. DOI ScienceOn |